Iain Hunter

Professor Iain Hunter is affiliated with the University of Strathclyde's Strathclyde Institute of Pharmacy and Biomedical Sciences. His research focuses on antibiotic resistance, Streptomyces species genetics, and antibacterial activity, contributing to UN Sustainable Development Goals related to health and innovation. He leads/co-leads projects such as 'Novel Therapeutics for Candida Infections' (2023–2026, CSO-funded) and 'Using Microarrays to Investigate Lineage in an Antibiotic-Producing Bacterium.'

His work includes impactful projects like commercializing non-invasive wound monitoring systems and advancing MGB Biopharma’s therapies for infections. He holds board memberships at Acies Bio Limited and SQA. Key research interests span bacterial genetics, metabolic engineering, and clinical applications of antibiotics.